E-mail Updates- Home
- Search for Research Summaries, Reviews, and Reports
EHC Component
- EPC Project
Topic Title
Related Products for this Topic
- Research Protocol Dec. 1, 2010
- Clinician Summary Apr. 10, 2013
- Consumer Summary Apr. 10, 2013
- Executive Summary Aug. 14, 2012
Education Resources for this Topic
Research Review - Final – Aug. 14, 2012
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
Formats
- View PDF (PDF) 6.8 MB
- Web Version (NLM Site)
- Help with Viewers, Players, and Plug-ins
Notice of Erratum: On August 20, 2012, Appendix O was updated to clarify that the route of administration for INVEGA SUSTENNA is IM injection (dosage 39 mg - 234 mg) and the route of administration for RISPERIDOL CONSTA is IM injection (dosage 25 mg).
Persons using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us.
Return to Top of Page
